Philip Morris International Inc. (NYSE:PM) Consumer Analyst Group of New York (CAGNY) Conference February 21, 2024 10:00 AM ET Company Participants Jacek Olczak - Chief Executive Officer Emmanuel Babeau - Chief Financial Officer Stacy Kennedy - President of Americas & CEO of PMI U.S. Stefano Volpetti - President, Smoke-Free Inhaled Products & Chief Consumer Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Bonnie Herzog And thanks again for joining us today. So it's my pleasure to welcome P ...

Financial Forecast and Performance - The company reaffirms its 2024 full-year reported diluted EPS forecast of $5.90 to $6.02, representing a currency-neutral increase of 7% to 9% compared to the adjusted diluted EPS of $6.01 in 2023 [2] - Adjustments for 2024 include asset impairment, termination costs, tax impacts, and other items totaling $0.42 per share, with an additional unfavorable currency impact of $0.11 per share [2][3] - Adjusted diluted EPS for 2024 is projected to be $6.32 to $6.44, excluding adjustments and currency impacts [3] Smoke-Free Transformation and Product Portfolio - The company is progressing towards becoming a substantially smoke-free business by 2030, with smoke-free products accounting for approximately 37% of total full-year 2023 net revenues [3][8] - PMI has invested $12.5 billion since 2008 to develop and commercialize smoke-free products, aiming to end cigarette sales [8] - As of December 31, 2023, PMI's smoke-free products were available in 84 markets, with an estimated 20.8 million adults having switched to IQOS and stopped smoking [8] - The company's multi-category portfolio includes leading premium brands in heat-not-burn and oral nicotine, such as IQOS and ZYN [3][8] Strategic Initiatives and Acquisitions - PMI completed the acquisition of Swedish Match in 2022, creating a global smoke-free champion with a focus on oral nicotine delivery [8] - The company is conducting a strategic review of the U.S. cigar business as part of its integration efforts with Swedish Match [3] - PMI aims to expand into wellness and healthcare areas through its Vectura Fertin Pharma business, leveraging its expertise in life sciences [8] Market and Regulatory Environment - The U.S. Food and Drug Administration has authorized versions of PMI's IQOS Platform 1 devices and Swedish Match's General snus as Modified Risk Tobacco Products [8] - The company faces challenges such as excise tax increases, regulatory restrictions, and health concerns related to tobacco and nicotine products [6] - PMI is subject to risks from global economic, regulatory, and political developments, as well as the impact of conflicts like Russia's invasion of Ukraine [6]

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial Officer, at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 21, 2024, at 10:00 a.m. ET. The live webcast and presentation slides will be available at www.pmi.com/2024cagny. The webcast replay will be available at the same link until Friday, March 22, ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Styl ...

Championing a Smoke-Free World 2023 Fourth-Quarter and Full-Year Results February 8, 2024 Introduction • A glossary of terms, including the definition for smoke-free products(a) a ...

Philip Morris International Inc. (NYSE:PM) Q4 2023 Earnings Conference Call February 8, 2024 9:00 AM ET Company Participants James Bushnell - VP, IR, and Financial Communications Jacek Olczak - Chief Executive Officer Emmanuel Babeau - Chief Financial Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Gaurav Jain - Barclays Pamela Kaufman - Morgan Stanley Mirza Faham Ali Baig - UBS Callum Elliott - Bernstein Matthew Smith - Stifel Operator Good day, everyone and welcome to the Philip Morris ...

Michael M. Santiago/Getty Images News Philip Morris International Inc. (NYSE:PM) Q4 results can be described as mixed between a headline EPS miss, while revenue came in slightly above expectations. This report caps off a volatile year for the stock amid not only a tough macro environment, thinking about the impact of high-interest rates, but also the industry backdrop facing a secular decline in traditional cigarettes. That being said, the company appears to be finding success with its ongoing transformatio ...

Shares of Philip Morris International (PM -3.01%) were sliding today after the tobacco company missed estimates on the bottom line in its fourth-quarter earnings report and offered guidance that also missed the mark.As a result, the stock was down 2.6% at 1:44 p.m. Thursday after trading as far down as 3.4% earlier in the session. Iqos spoils Philip Morris' quarterPhilip Morris has spent much of the past decade trying to pivot to its next-gen Iqos heat-not-burn product, but results from that transformation ...

For the quarter ended December 2023, Philip Morris (PM) reported revenue of $9.05 billion, up 11% over the same period last year. EPS came in at $1.36, compared to $1.39 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $8.96 billion, representing a surprise of +0.98%. The company delivered an EPS surprise of -5.56%, with the consensus EPS estimate being $1.44.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street e ...

Philip Morris International Inc. (PM) posted fourth-quarter 2023 results, wherein the bottom line fell short of the Zacks Consensus Estimate. However, the top line increased year over year and beat the Zacks Consensus Estimate. The company continued to benefit from pricing power, along with strength in IQOS and ZYN.The company entered 2024 on a solid note and expects it to be another strong year, backed by organic smoke-free net revenue and profit growthQuarter in DetailAdjusted earnings per share (EPS) cam ...